NOT MEDICAL ADVICE. No information on this site should be considered medical advice. Research peptides are not intended for human consumption — in-vitro lab use only. Consult a physician prior to introducing anything into the human body.
Peptide HubResearch Peptide Wiki
Support Us Join

Even a Third-Party COA Isn’t Enough: Batches, Bioactivity, and the Retest Habit

A COA — even a genuinely third-party one — describes one sample, tested at one time for a few chosen properties. It is necessary and insufficient: the gap between the certificate and the vial in your hand is where the industry hides.

What a COA actually certifies

A certificate of analysis certifies that a particular sample met particular specifications — typically identity and purity by HPLC or mass spectrometry — on a particular date, in a particular lab. It does not certify your vial. It does not certify the batch. It does not certify what happens after six months on a shelf or seven days reconstituted in your refrigerator.

The batch problem

Peptide synthesis is batch chemistry. Two lots from the same supplier can differ in purity, impurity profile, salt form, and water content, and a beautiful COA for lot A is silent about lot B. Yet most vendors advertise purity as a property of the product rather than of the batch. The minimum habit: confirm that the lot number printed on your vial matches the lot on the COA, and treat any mismatch as an automatic fail.

HPLC purity is not activity

Purity percentages describe relative peak area at a detector wavelength. They do not prove the sequence is correct — that requires mass spectrometry, and confirming the intended sequence is a further step. They do not reliably expose wrong-sequence impurities that co-elute, and they say nothing about oxidation, aggregation, or misfolding. A pure peptide that is the wrong molecule — or the right molecule in the wrong form — is not a product; it is a chemistry accident with paperwork attached.

What is usually missing from the certificate

  • Endotoxin testing (LAL) — the assay most relevant to whether a reconstituted injection makes someone sick, and the one most often absent.
  • Sterility and bioburden — rarely tested, rarely true.
  • Fill accuracy — a vial labeled 10 mg may hold meaningfully more or less.
  • Peptide content — the percentage of actual peptide versus salt, counterion, and water.
  • Stability — a COA is a photograph taken on day zero; degradation over time is untested.

Independent retesting: the only real answer

For anything intended for injection, the standard that matters is your own test: send an aliquot from the actual vial — ideally from several vials of the same lot — to an independent analytical lab, and compare the results against the vendor’s claims. This is routine in industry and vanishingly rare among retail buyers, which is exactly why it is so informative. Vendors confident in their process tend to welcome it; the rest tend to produce reasons why it is unnecessary. A single independent assay costs a small fraction of what a bad batch can cost. Keep a log — lot number, reconstitution date, storage, results — because over time that log is the only quality system that actually belongs to you.

The bottom line: the certificate is a starting point for diligence, not the endpoint. Batch matching, honest awareness of what each method can and cannot show, and the retest habit are what convert paperwork into evidence — and in this market, evidence is the whole game.